Collection 專利 [0/26] 期刊論文 [80/81] 圖書 [1/1] 會議論文/會議摘要 [2/2] Siblings 余佳益 [17/17] 余冠儀 [40/40] 冷治湘 [61/89] 劉士任 [121/149] 劉家齊 [45/52] 司徒惠康 [71/72] 吳綺容 [84/84] 周彥宏 [46/58] 宋旺洲 [33/34] 廖經倫 [32/32] 張仲明 [2/2] 張堯 [44/44] 曾凡真 [34/34] 曾才騰 [9/9] 李敏西 [60/64] 杜鴻運 [50/50] 楊采菱 [133/134] 潘建雄 [18/19] 羅秀容 [96/97] 胡勇誌 [23/23] 莊再成 [104/153] 蕭樑基 [158/161] 蘇益仁(2002-2015) [190/195] 許修誌(2005-2010) [1/1] 許素菁 [27/30] 謝鐸源(2006-2014) [20/27] 郭書辰 [139/141] 陳俊宏 [61/62] 陳宜君 [38/38] 陳逢叡 [40/40] 黃明熙 [51/64] 黃盈綺 [6/6] 齊嘉鈺 [46/46] McDonald LC(1998-2000) [12/12] 何曼德(1997-2002) [38/39] 其他 [177/177] 朱清良(2005-2007) [4/4] 梁蘭蘭(1998-2006) [6/6] 黃崑巖(1999-2004) [4/4] Community Statistics 近3年內發表的文件:16(14.55%) 含全文筆數:83(75.45%) 文件下載次數統計 下載大於0次:83(100.00%) 下載大於100次:79(95.18%) 檔案下載總次數:44480(0.83%) 最後更新時間: 2024-12-01 03:13 Top Upload Loading... Top Download Loading... Recent Submissions Boosting DNA vaccine power by lipid... Effect of C-type lectin 16 on dengu... SARS-CoV-2 spike-FLIPr fusion prote... Lipid nanoparticle-encapsulated DNA... Co-delivery of a trimeric spike DNA... Mechanical transmission of dengue v... Recombinant lipidated FLIPr effecti... Omicron-specific mRNA vaccine induc... Formulation of SARS-CoV-2 spike pro... Glycosylation and S-palmitoylation ...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 51-100 of 110. (3 Page(s) Totally) << < 1 2 3 > >> View [10|25|50] records per page

Date	Title	Relation
2015-06	Recombinant lipoproteins as novel vaccines with intrinsic adjuvant	Advances in Protein Chemistry and Structural Biology. 2015 Jun;99:55-74.
2015-05-11	佐劑	I483735/2015-05-11
2015-03-06	脂質化腫瘤相關抗原及其免疫治療的組成物及方法	HK1171457/2015-03-06
2014-10-29	脂质化肿瘤相关抗原及其免疫治疗的组成物及方法	ZL201080027969.8/2014-10-29
2014-09	A poorly neutralizing IgG2a/c response elicited by a DNA vaccine protects mice against Japanese encephalitis virus	Journal of General Virology. 2014 Sep;95(Pt 9):1983-1990.
2014-07-21	登革熱病毒胜肽疫苗及其製備與使用方法	I445547/2014-07-21
2014-07-08	Method of producing lipidated polypeptides	US8771990B2/2014-07-08
2014-05	Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells	Journal of Immunology. 2014 May;192(9):4233-4241.
2014-04-23	Lipidated tumor-associated antigens and immunotherapeutic compositions	EP2445927/2014-04-23
2014-03-19	Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy	Molecular Cancer. 2014 Mar 19;13:Article number 60.
2014-03	Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity	Vaccine. 2014 Mar;32(12):1346-1353.
2014-03	A purified recombinant lipopeptide as adjuvant for cancer immunotherapy	BioMed Research International. 2014 Mar;2014:Article number 349783.
2014-02-25	Lipidated tumor-associated antigens and immunotherapeutic compositions	US8658176B2/2014-02-25
2014-02-25	Lipidated polyepitope vaccines	US8658767B2/2014-02-25
2014-01	Disintegration and cancer immunotherapy efficacy of a squalane-in-water delivery system emulsified by bioresorbable poly(ethylene glycol)-block-polylactide	Biomaterials. 2014 Jan;35(5):1686-1695.
2014-01	The fate of regulatory T cells: Survival or apoptosis	Cellular and Molecular Immunology. 2014 Jan;11(1):11-13.
2013-09-21	脂質化腫瘤相關抗原及其免疫治療的組成物及方法	I409275/2013-09-21
2013-09-19	Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancement	PLoS Neglected Tropical Diseases. 2013 Sep 19;7(9):Article number e2432.
2013-09	Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III	Microbes and Infection. 2013 Sep;15(10-11):719-728.
2013-07	A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates	Archives of Virology. 2013 Jul;158(7):1523-1531.
2013-06-18	Immunogenic peptides of tumor associated antigen L6 and uses thereof in cancer therapy	US8465756B2/2013-06-18
2013-06-18	Adjuvants	US8466259B2/2013-06-18
2013-06-11	腫瘤相關抗原之免疫性肽類及其於癌症治療上的用途	I398262/2013-06-11
2013-05-21	Multi-phase emulsions based on amphiphilic block copolymers	US8444993B2/2013-05-21
2013-05	Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines	Journal of Immunology. 2013 May;190(10):5065-5077.
2013-04-23	Production of lipidated proteins in E. coli	US8426163B2/2013-04-23
2013-02-01	以兩性團聯共聚物為基礎的複合相乳狀液	I383806/2013-02-01
2013-01	Mesenchymal stem cells promote neutrophil activation by inducing IL-17 production in CD4+ CD45RO+ T cells	Immunobiology. 2013 Jan;218(1):90-95.
2012-11-11	於大腸桿菌製造脂質化蛋白質	I376385/2012-11-11
2012-10-16	Lipidated vaccine against dengue virus infection	US8287880B2/2012-10-16
2012-08	CD4+ T cells disarm or delete cytotoxic T lymphocytes under IL-17–Polarizing conditions	Journal of Immunology. 2012 Aug;189(4):1671-1679.
2012-05	Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses	PLoS Neglected Tropical Diseases. 2012 May;6(5):Article number e1645.
2012-04	A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo	Journal of Immunotherapy. 2012 Apr;35(3):235-244.
2011-12-11	脂質化序列及其用於在大腸桿菌製造脂質化蛋白質	I354023/2011-12-11
2011-08	A novel single-dose dengue subunit vaccine induces memory immune responses	PLoS ONE. 2011 Aug;6(8):Article number e23319.
2011-07-19	Consensus dengue virus envelope protein domain III polypeptides (cED III) and their methods of use	US7981431B2/2011-07-19
2011-04	Increased expression of IL-21 reduces tumor growth by modulating the status of tumor-infiltrated lymphocytes	Immunobiology. 2011 Apr;216(4):491-496.
2011-04	Vaccine delivery systems based on amphiphilic bioresorbable polymers and their role in vaccine immunogenicity	Immunogenicity. 2011 Apr;67-90.
2010-11-16	Lipidating sequences and use thereof for producing lipidated proteins in E. coli	US7833776B2/2010-11-16
2010-08	Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in mice	PLoS ONE. 2010 Aug;5(8):Article number e12279.
2010-07	A recombinant lipoprotein containing an unsaturated fatty acid activates NF-kappaB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide	Molecular Immunology. 2010 Jul;47(11-12):2015-2021.
2010-06	IL-6-transfected tumor cells modulate the status of CD8+ and CD4+ T cells to control tumor growth	Immunobiology. 2010 Jun;215(6):486-491.
2010-02	Highly sensitive rare cell detection based on quantum dot probe fluorescence analysis	Analytical and Bioanalytical Chemistry. 2010 Feb;396(3):1135-1141.
2009-11-01	Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization	Cancer Biology and Therapy. 2009 Nov 1;8(21):2025-2032.
2009-08	Formulation and immunological evaluation of novel vaccine delivery systems based on bioresorbable poly(ethylene glycol)-block-poly(lactide-co-epsilon-caprolactone)	Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2009 Aug;90(2):832-841.
2009-08	Development of multi-phase emulsions based on bioresorbable polymers and oily adjuvant	Pharmaceutical Research. 2009 Aug;26(8):1856-1862.
2009-05-22	Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus	Biochemical and Biophysical Research Communications. 2009 May 22;383(1):27-31.
2009-05	Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccine	Microbes and Infection. 2009 May;11(6-7):654-660.
2009-02-25	A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design	Vaccine. 2009 Feb 25;27(9):1400-1409.
2009-02	A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity	Microbes and Infection. 2009 Feb;11(2):288-295.

Showing items 51-100 of 110. (3 Page(s) Totally) << < 1 2 3 > >> View [10|25|50] records per page